Avestar Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $610K | Buy |
8,489
+568
| +7% | +$43.8K | 0.04% | 309 |
|
|
2025
Q4 | $629K | Buy |
7,921
+886
| +13% | +$69.8K | 0.04% | 296 |
|
|
2025
Q3 | $530K | Sell |
7,035
-293
| -4% | -$20.1K | 0.03% | 330 |
|
|
2025
Q2 | $506K | Buy |
7,328
+2,631
| +56% | +$173K | 0.03% | 323 |
|
|
2025
Q1 | $318K | Buy |
+4,697
| New | +$281K | 0.03% | 365 |
|
|
2024
Q4 | – | Sell |
-5,178
| Closed | -$326K | – | 526 |
|
|
2024
Q3 | $326K | Buy |
+5,178
| New | +$302K | 0.03% | 331 |
|
|
2024
Q2 | – | Sell |
-10,699
| Closed | -$853K | – | 471 |
|
|
2024
Q1 | $853K | Buy |
10,699
+4,544
| +74% | +$347K | 0.09% | 169 |
|
|
2023
Q4 | $486K | Buy |
6,155
+29
| +0.5% | +$2.06K | 0.06% | 201 |
|
|
2023
Q3 | $428K | Sell |
6,126
-87
| -1% | -$6.16K | 0.06% | 182 |
|
|
2023
Q2 | $430K | Sell |
6,213
-985
| -14% | -$70.1K | 0.07% | 164 |
|
|
2023
Q1 | $535K | Sell |
7,198
-1,272
| -15% | -$107K | 0.1% | 138 |
|
|
2022
Q4 | $789K | Sell |
8,470
-595
| -7% | -$57.4K | 0.14% | 92 |
|
|
2022
Q3 | $865K | Buy |
9,065
+1,440
| +19% | +$143K | 0.22% | 72 |
|
|
2022
Q2 | $707K | Sell |
7,625
-11,151
| -59% | -$1.09M | 0.17% | 92 |
|
|
2022
Q1 | $1.9M | Sell |
18,776
-1,336
| -7% | -$140K | 0.3% | 62 |
|
|
2021
Q4 | $2.08M | Sell |
20,112
-1,055
| -5% | -$97.5K | 0.25% | 85 |
|
|
2021
Q3 | $1.8M | Buy |
21,167
+2,019
| +11% | +$169K | 0.23% | 102 |
|
|
2021
Q2 | $1.6M | Buy |
19,148
+4,481
| +31% | +$367K | 0.21% | 120 |
|
|
2021
Q1 | $1.11M | Buy |
14,667
+5,802
| +65% | +$423K | 0.25% | 86 |
|
|
2020
Q4 | $605K | Buy |
8,865
+2,149
| +32% | +$140K | 0.17% | 113 |
|
|
2020
Q3 | $400K | Buy |
6,716
+2,726
| +68% | +$170K | 0.13% | 134 |
|
|
2020
Q2 | $259K | Buy |
+3,990
| New | +$251K | 0.11% | 150 |
|
|
2019
Q3 | – | Sell |
-901
| Closed | -$46K | – | 323 |
|
|
2019
Q2 | $46K | Buy |
901
+166
| +23% | +$8.94K | 0.03% | 302 |
|
|
2019
Q1 | $37K | Sell |
735
-216
| -23% | -$13.3K | 0.02% | 318 |
|
|
2018
Q4 | $57K | Buy |
951
+156
| +20% | +$11.6K | 0.04% | 244 |
|
|
2018
Q3 | $60K | Sell |
795
-82
| -9% | -$5.86K | 0.03% | 257 |
|
|
2018
Q2 | $51K | Sell |
877
-1,057
| -55% | -$69.7K | 0.03% | 272 |
|
|
2018
Q1 | $93K | Buy |
1,934
+58
| +3% | +$4.16K | 0.06% | 179 |
|
|
2017
Q4 | $122K | Buy |
+1,876
| New | +$136K | 0.09% | 132 |
|
Other funds holding CVS
VCM
VPM
Avestar Capital's CVS Position: Q1 2026 in Review
Avestar Capital increased its CVS Health (CVS) stake by 7.2% in Q1 2026, buying an estimated $43.8K and bringing the position to 8,489 shares worth $610K. The position accounts for 0.04% of the portfolio, ranked #309.
Avestar Capital first reported a position in CVS in Q4 2017 and has held it in 29 quarters since. The position peaked at $2.08M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Avestar Capital held 8,489 shares of CVS Health worth $610K as of Q1 2026.
- Avestar Capital bought 568 CVS Health shares in Q1 2026, an estimated $43.8K.
- CVS Health made up 0.04% of Avestar Capital's portfolio in Q1 2026, its #309 holding.
- Avestar Capital first reported a position in CVS Health in Q4 2017 and has held it in 29 quarters since.
- Avestar Capital's CVS Health position peaked at $2.08M in Q4 2021.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.